• Using gene expression data from the GUDMAP database, we selected Sema3f as an anti-angiogenic candidate gene that may exclude developing blood vessels from the cap mesenchyme (groups of nephron progenitor cells) in the murine metanephric (permanent) kidney.
Introduction
In his Collected Essays, T.H. Huxley referred to 'The great tragedy of Science -the slaying of a beautiful hypothesis by an ugly fact'. This report describes just such a slaying, of a hypothesis about how the arrangement of blood vessels is controlled in the developing kidney.
The major function of the adult kidney is to filter blood. Blood enters the kidneys via the renal arteries before being transported to the glomerular capillaries where small molecules are filtered into the Bowman's capsule. After filtration, useful molecules are reabsorbed by tubular cells and collected by peritubular capillaries, while waste and toxins are excreted as urine. This task requires a complex vasculature that must be assembled accurately during development.
Mouse metanephric (permanent) kidney development begins at E10.5 when the ureteric bud, the precursor of the collecting duct and ureter, evaginates from the caudal end of the Wolffian/nephric duct in response to glial cell-line-derived neurotrophic factor (GDNF; Sainio et al., 1997; Costantini & Kopan, 2010) . The ureteric bud invades a mass of undifferentiated cells, the metanephrogenic mesenchyme, and begins to branch. As the ureteric bud branches, it induces nephron formation by provoking groups of nephron progenitor cells to undergo mesenchymal-to-epithelial transitions (Carroll et al., 2005) . The nephron progenitor cells reciprocate by inducing branching of the ureteric bud (Majumdar et al., 2003; Costantini & Shakya, 2006; Cebrian et al., 2014) . Prior to their differentiation, nephron progenitor cells situate around ureteric bud tips in cell populations known as the cap mesenchyme (they 'cap' the ureteric tips: Reinhoff, 1922) . As the ureteric bud bifurcates, the overlaying cap mesenchymal population splits so that each new ureteric tip inherits a population of cap mesenchymal cells; this occurs in cycles throughout kidney development (Short et al., 2014) .
Recently, we have shown that blood vessels pattern in cycles alongside the splitting of the cap mesenchyme and the branching of the ureteric bud in the developing kidney (Munro et 
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al., 2017). Vascular plexuses form around the cap mesenchyme, but they do not enter it. As the cap splits, endothelia migrate through the fissure to form new vascular plexuses. The mechanism by which this happens is not understood, but we hypothesised that at least part of the pattern, the avoidance of the cap mesenchyme by the vasculature, may arise through the cap mesenchyme expressing anti-angiogenic signalling molecules.
Certain class-3 semaphorins have a known capacity to act as anti-angiogenic signalling molecules. An example is semaphorin-3f (Sema3f; Bielenberg et al., 2004; Guttmann-Raviv et al., 2007; Parker et al., 2010; Buehler et al., 2013; Guo et al., 2013) . Although classically thought of as an axonal guidance molecule, Sema3f is highly expressed in multiple nonneuronal organs during development, such as the skin, lung, and kidney (Giger et al., 1998) .
Its functions in these tissue types are poorly understood.
In vascular development, Sema3f inhibits angiogenesis by interacting with its receptors on the endothelial cell membrane, neuropilin-1 (Nrp1; its low-affinity receptor) and neuropilin-2 (Nrp2; its high-affinity receptor; Guo et al., 2013; Sakurai et al., 2012) . Sema3f/Nrp signalling results in the suppression of endothelial cell survival, proliferation, and migration (GuttmannRaviv et al., 2007; Procaccia et al., 2014; Nakayama et al., 2015) .
Here, we characterise the expression patterns of Sema3f, Nrp1, and Nrp2 in the developing kidney. We show that they are expressed in a manner perfectly compatible with the hypothesis that they mediate exclusion of vasculature from caps, but go on to show that they are not, in fact, required for this aspect of vascular plexus patterning.
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Results and Discussion
Selection of a cap mesenchyme-expressed, anti-angiogenic candidate gene
We previously demonstrated that renal endothelia pattern around, but do not enter, the cap mesenchyme in the nephrogenic zone of the developing kidney (Munro et al., 2017; Fig. 1A) .
Patterning occurs in cycles throughout most of embryonic kidney development, and we hypothesised that anti-angiogenic signals produced by the cap mesenchyme might be responsible for it being avascular. To test this, we generated a list of criteria to be met by cap mesenchyme-expressed candidate genes whose proteins might inhibit angiogenesis (Fig. 1B) . We reviewed the literature to produce a list of 39 known anti-angiogenic genes and used microarray data from the GenitoUrinary Development Molecular Anatomy Project (GUDMAP) database (Brunskill et al., 2009; Harding et al., 2011) to assess their relative expression in the cap mesenchyme (Fig. 2) . Of the genes investigated, isthmin-1 (Ism1), semaphorin-3f (Sema3f), and suppressor of cytokine signalling-3 (Socs3) met our initial criteria as candidate genes as they are highly expressed in the cap mesenchyme during the embryonic (E15.5) and early postnatal phase (at least at one age between P0-P4; Fig. 1C and Fig. 2 ).
The next condition to be met was that the relative expression of the gene had to be lower in the nephrogenic interstitium (which becomes vascularized) than the cap mesenchyme (which does not): this was true for all three of these candidate genes at E15.5 (Fig. 1D) . The anti-angiogenic function of the protein also had to be mediated through cell non-autonomous signalling (i.e. via secretion from the cap mesenchyme or presentation on cap mesenchyme membranes so it can exert its effect on the nearby endothelia). Socs3 is a Stat-inhibiting, intracellular protein (Starr et al., 1997) and its anti-angiogenic effect is endothelial-cell autonomous (Stahl et al., 2012; Rao et al., 2015) : it was therefore discounted as a possible candidate gene.
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Ism1 and Sema3f are secreted proteins, and their anti-angiogenic properties are exerted when they bind to their receptors on the endothelial cell membrane: receptor-ligand binding leads to the activation of signalling pathways that prevent endothelial cell survival and proliferation (Guttmann-Raviv et al., 2007; Xiang et al., 2011; Rao et al., 2015) .
Consequently, the receptors for Ism1 and Sema3f would need to be expressed in the plexus endothelia for them to transduce their signals. The receptors for Ism1 are integrin alpha-V (Itgav; Zhang et al., 2011) and 78 kDa glucose-regulated protein homolog (Grp78; Chen et al., 2014) , and, based on microarray data, they were expressed weakly in renal endothelia (Fig. 1E) . In contrast, the expression of the Sema3f receptors, neuropilin-1 and neuropilin-2 (Nrp1 and Nrp2, respectively), was high in renal endothelia (Fig. 1E ). Based on these data, we further investigated the Sema3f/Nrp signalling pathway in vascular patterning in the nephrogenic zone.
Complementary expression pattern of Sema3f and Nrp2 in the developing kidney
The GUDMAP microarray data indicating that Sema3f is highly expressed in the cap mesenchyme at E15.5 has been validated at the RNA level by in situ hybridisation of wholemount kidneys (data made available on GUDMAP by the McMahon lab; Fig 3A-A') . Although GUDMAP has little data on renal Sema3f expression prior to E15.5, data from the Allen Brain Atlas (Lein et al., 2007) show that Sema3f is also expressed in the kidney at E11.5 and E13.5 (Fig 3B-C' ). At the earliest stages of renal organogenesis (E10.5-E11.5), the kidney is predominantly avascular, despite being surrounded by blood vessels (Munro et al., 2017) .
As Sema3f is expressed throughout the metanephrogenic mesenchyme at E11.5 (Fig. 3B -B'), its anti-angiogenic function could prevent premature renal vascularisation.
To investigate the localisation of the Sema3f protein, we stained whole-mount kidneys at E12.5 and E15.5 with anti-Sema3f. Kidneys were cleared with benzyl alcohol/benzyl benzoate (BABB) prior to imaging. At E12.5, Sema3f localises in tubular epithelia (in 
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agreement with Villegas and Tufro, 2002) and in the presumptive cap mesenchyme (Fig. 3D ).
At E15.5, we assessed co-localisation of Sema3f with the cap mesenchyme marker, integrin alpha-8 (Müller et al., 1997) . Sema3f staining was not exclusive to the cap mesenchyme: it was observed in tubular epithelia, the cap mesenchyme, and the nephrogenic interstitium ( Fig 3E) . This is unsurprising as Sema3f is a secreted protein whose localisation is not restricted to the cell that produces it. Indeed, Sema3f would be required to exit the cap to bind to, and inhibit, endothelia in the nephrogenic interstitium.
To respond to Sema3f, the endothelia in the nephrogenic interstitium would have to express either Nrp1, Nrp2, or both. Confocal z-stack images of an E15. 
Expression of Nrp1 and Nrp2 in the developing kidney and ureter
Studies suggest that Nrp1 and Nrp2 are differentially expressed in arterial, venous, and lymphatic endothelia (Herzog et al., 2001) . Nrp2 is preferentially expressed in lymphatic vessels and veins, whereas Nrp1 is expressed in arteries. We corroborated these findings by co-staining Nrp1 + and Nrp2 + endothelia with venous and lymphatic markers in the ureter ( In the E11.5 and E12.5 kidney, almost all renal blood vessels expressed Nrp2, but few vessels expressed Nrp1 (Fig. 6A, B) . By E13.5, Nrp1 had become highly expressed in renal arteries ( Fig. 6C-E) . The endothelial plexuses in the E13.5 kidney had many Nrp2 + cells, but few discernible Nrp1 + cells. In contrast, by E18.5 the plexus endothelia expressed Nrp2 as well as Nrp1 (Fig 6E, F) . Nrp2 is highly enriched in endothelial tip cells (Siemerink et al., 2012) . Based on the location of the Nrp2 + plexus endothelia at the vascular front (the site of new blood vessel formation), we speculate that these Nrp2 + cells are the endothelial tip cells in the kidney; however, there are no known specific endothelial tip cell markers to verify this hypothesis.
In the ureter, anti-Nrp2 staining is very strong in lymphatic vessels (Fig 5A-C) . We next explored whether Nrp2 + lymphatic vessels form within the kidney. To do this, we cleared whole-mount E15.5 kidneys with BABB prior to imaging. We demonstrate that Nrp2 + lymphatic vessels form rings around the ureter and that these vessels connect with the lymphatic vessels in the renal pelvis (Fig 7A-B ). In agreement with previous studies (Tanabe et al., 2012) , renal Nrp2 + lymphatic vessels extend along the segmental vasculature from the renal pelvis (Fig 7C) . The Nrp2 + lymphatic vessels in the kidney and ureter are in connection with a network of Nrp2 + lymphatic vessels that supply the adrenal gland, gonad, mesonephros, and ureter ( Fig 7A; Supplementary movie 2). The caudal portions of euthanized P0 Sema3f mice were sent at 4°C to the University of Edinburgh where the kidneys were dissected and immunostained (for details, see Davies, 2006) . The Sema3f knockout mouse line has previously been described (Walz et al., 2007) .
Sema3f and
Sema3f mutant mice were bred for over 9 generations into a C57BL/6 genetic background
(Charles River Laboratories, Frederick, MD). Tissue from E18.5 Nrp2 transgenic mouse embryos was kindly provided by Alex Kolodkin and Qiang Wang (Johns Hopkins University).
Nrp2 mutant mice were bred into the C57BL/6 genetic background, and this mouse line has previously been described (Giger et al., 2000) .
Immunohistochemistry
Embryonic kidneys were dissected as previously described (Davies, 2010) . Kidneys were then fixed in methanol (pre-cooled at -20°C) for 1 hr. Fixed kidneys were either stored in methanol at -20°C (for up to 6 months) or directly processed following fixation. PBS was used to rinse off the methanol from the kidneys (3 x 20 mins) and the kidneys were blocked with 1x PBS with 5% donkey serum (Sigma, D9663) and 2.5% BSA (Sigma, A9647) for 1 hrovernight. Kidneys were incubated with the following primary antibodies overnight at 4°C:
rat-anti-CD31 (1:100; BD Pharmingen; 550274), goat-anti-collagen IV (1:100;
Merckmillipore; AB769), rat-anti-EphB4 (1:100; abcam; ab73259), rabbit-anti-laminin (1:100; Sigma; L9393), rabbit-anti-Lyve1 (1:100; Abcam; ab33682), rabbit-anti-Nrp1 (1:100; abcam; PBS (3 x 5 mins, then 4 x 1 hr), before being mounted onto glass slides using Vectashield (Vectorlabs, H1000) as a mounting medium. Benzyl alcohol/benzyl benzoate (BABB)
clearing whole-mount immunofluorescence was performed as previously described (Munro et al., 2017) . BABB clearing was used for Fig. 3D -E and Fig. 7 .
Microscopy
Images were captured using the Nikon A1R and Zeiss LSM800 confocal microscopes.
Objective lenses of 4-60x were used (lenses were oil-immersed from 40x upwards).
Statistics and data presentation
95% confidence intervals for binary (yes/no) data were calculated using the formula t=1.64SQRT(pq/n)+1/2n, where t is the 95% confidence interval, p is the proportion positive, q is 1-p, and n is the number examined. IMARIS (version 8.3.1) and Adobe premiere pro CC (2015) were used to prepare the supplementary movies.
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John Genetic ablation of Sema3f had no effect on vascular patterning around the caps (representative images from n = 2-3 P0 mice; 4-6 kidneys per genotype; 9-12 total fields of staining per genotype). (C-D) Genetic ablation of Nrp2 had no effect on vascular patterning around the caps (representative images from n = 1-3 E18.5 embryos; 2-6 total fields of staining per genotype). Asterisks in the genotyping gel images represent the embryos/pups whose kidneys are shown in the representative images. Scale bars = 100 µm.
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